| Company Name: |
Shanghai Tekanbio Pharm-Tech Co., Ltd. Gold
|
| Tel: |
021-50896099 18017206244 |
| Email: |
sales@tekanbio.com |
| Products Intro: |
Product Name:(S)-N-[2-(4-Ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl)ethyl]-N-isopropylmethanesulfonamide CAS:2356229-14-4 Purity:98% Package:1g;10g
|
| Company Name: |
Shochem(Shanghai)Co.,Ltd
|
| Tel: |
+86-021-51783479 +86-13816874662 |
| Email: |
info@shochem.com |
| Products Intro: |
Product Name:Methanesulfonamide, N-[2-[(4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]ethyl]-N-(1-methylethyl)- CAS:2356229-14-4 Purity:98% Package:1g;10g;100g
|
|
| | Methanesulfonamide, N-[2-[(4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]ethyl]-N-(1-methylethyl)- Basic information |
| Product Name: | Methanesulfonamide, N-[2-[(4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]ethyl]-N-(1-methylethyl)- | | Synonyms: | Methanesulfonamide, N-[2-[(4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]ethyl]-N-(1-methylethyl)-;Belotecan-Ms;(S)-N-[2-(4-Ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-11-yl)ethyl]-N-isopropylmethanesulfonamide;T01-1;N-[2-[(19S)-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0211.0??.01?2o]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-10-yl]ethyl]-N-isopropyl-methanesulfonamide | | CAS: | 2356229-14-4 | | MF: | C26H29N3O6S | | MW: | 511.59 | | EINECS: | | | Product Categories: | | | Mol File: | 2356229-14-4.mol | ![Methanesulfonamide, N-[2-[(4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]ethyl]-N-(1-methylethyl)- Structure](CAS/20210111/GIF/2356229-14-4.gif) |
| | Methanesulfonamide, N-[2-[(4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]ethyl]-N-(1-methylethyl)- Chemical Properties |
| Boiling point | 848.0±75.0 °C(Predicted) | | density | 1.45±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C, protect from light | | form | Solid | | pka | 11.24±0.20(Predicted) | | color | Off-white to yellow | | InChIKey | PGWIUEMZGPWFBB-SANMLTNESA-N | | SMILES | CS(N(CCC1C2C(N=C3C4N(C(=O)C5COC(=O)[C@@](CC)(O)C=5C=4)CC3=1)=CC=CC=2)C(C)C)(=O)=O |
| | Methanesulfonamide, N-[2-[(4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]ethyl]-N-(1-methylethyl)- Usage And Synthesis |
| Uses | T01-1 is an anticancer agent (camptothecin derivative) with good anti-proliferative activity[1]. | | in vivo | T01-1 (1 mg/kg; i.v.; single) shows T1/2 values of 2.78 and 1.97 h in female and male rats, respectively[1]. | Animal Model: | Sprague Dawley rat (half male and half female)[1]. | | Dosage: | 1 mg/kg | | Administration: | Intravenous injection; single | | Result: | 1.19Pharmacokinetic Parameters of T01-1 in Sprague Dawley rat [1].
| IV (1 mg/kg) | | Female | Male | | AUCLast (ng/mL?h) | 437 | 214 | | Cmax (ng/mL) | 838 | 625 | | MRTINF (h) | 2.81 | 0.44 | | T1/2 (h) | 2.78 | 1.97 | | Tmax (h) | 0.08 | 0.08 |
|
| | References | [1] Li Deliang, et al. Camptothecin derivative and water-soluble prodrug, pharmaceutical composition preparation method, and application. Patent WO2020156189A1. |
| | Methanesulfonamide, N-[2-[(4S)-4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl]ethyl]-N-(1-methylethyl)- Preparation Products And Raw materials |
|